PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (Q63835591)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata |
clinical trial |
Statements
PEARLIII (English)
0 references
A Phase III, Multicentre, Clinical Study Investigating the Efficacy and Safety of 3-months Open-label Treatment With PGL4001, Followed by a Randomised, Double-blind Placebo Controlled Period of 10 Days Treatment With Progestin, in Subjects With Myomas and Heavy Uterine Bleeding. (English)
0 references
July 2010
0 references
November 2011
0 references
209
0 references
18 year
0 references
48 year
0 references